New England Journal of Medicine
N Engl J Med 2013; 368:207-217 DOI: 10.1056/NEJMoa1110039
ViewShort-course antiretroviral therapy (ART) in primary human immunodeficiency virus (HIV) infection may delay disease progression but has not been adequately evaluated.